Wiley Michael J 4
4 · Guardant Health, Inc. · Filed Nov 13, 2019
Insider Transaction Report
Form 4
Wiley Michael J
Chief Legal Officer
Transactions
- Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Exercise/Conversion
COMMON STOCK
2019-11-11$4.18/sh+6,779$28,336→ 179,516 total - Sale
COMMON STOCK
2019-11-11$72.12/sh−2,898$209,004→ 176,618 total - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2019-11-11−6,779→ 106,781 totalExercise: $4.18Exp: 2027-07-13→ COMMON STOCK (6,779 underlying) - Gift
COMMON STOCK
2019-10-10−40,000→ 172,737 total - Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Sale
COMMON STOCK
2019-11-11$73.08/sh−3,881$283,623→ 172,737 total
Footnotes (5)
- [F1]The Reporting Person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, if any.
- [F2]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.71 to $72.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.72 to $73.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.